Non-steroidal anti-inflammatory drug Indomethacin has shown excellent efficacy in the treatment of mild and moderate COVID-19 patients during the trial.
It was designed by (IIT) Madras. The study further revealed that Indomethacin works with all variants. “We had done two trials, one in the first wave and the other in the second wave," authors claime The study conducted at Panimalar Medical College and Research Institute was led by Dr Rajan Ravichandran, an Adjunct Faculty at IIT Madras and Director of Nephrology at MIOT hospitals.
And, it has been published in Nature Scientific Reports. "Indomethacin, with more than 20 lakh prescriptions per year in the US alone, is an established drug widely used since the 1960s to treat various types of inflammation-related" IIT Madras said in a statement.
Indian researchers are the first to show the efficacy of indomethacin through a randomized clinical trial though the scientific basis has been researched by Italian and US scientists., it also said.